{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:11:29Z","timestamp":1791583889684,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.actbio.2026.02.020","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:13:55Z","timestamp":1770999235000},"page":"609-621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Size-Transformable amphiphilic dendrimer-based drug Nanomicelles for enhanced tumor penetration in cancer chemotherapy"],"prefix":"10.1016","volume":"213","author":[{"given":"Wang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongqin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoping","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengmei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1683-3571","authenticated-orcid":false,"given":"Dandan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7503-8359","authenticated-orcid":false,"given":"Xiaoxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.actbio.2026.02.020_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.actbio.2026.02.020_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.actbio.2026.02.020_bib0003","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature03095","article-title":"Targeted cancer therapy","volume":"432","author":"Sawyers","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2026.02.020_bib0004","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41571-022-00685-3","article-title":"Mitigating acute chemotherapy-associated adverse events in patients with cancer","volume":"19","author":"Kuderer","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2026.02.020_bib0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","article-title":"Opportunities and challenges of radiotherapy for treating cancer","volume":"12","author":"Schaue","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.actbio.2026.02.020_bib0006","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMra1608986","article-title":"Recent developments in radiotherapy","volume":"377","author":"Citrin","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2026.02.020_bib0007","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41568-022-00496-9","article-title":"Cancer nanomedicine","volume":"22","author":"Bhatia","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2026.02.020_bib0008","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41568-025-00847-2","article-title":"Advancing engineering design strategies for targeted cancer nanomedicine","volume":"25","author":"Gomerdinger","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.actbio.2026.02.020_bib0009","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cclet.2020.11.029","article-title":"An overview of polymeric nanomicelles in clinical trials and on the market","volume":"32","author":"Zheng","year":"2021","journal-title":"Chin. Chem. Lett."},{"issue":"7","key":"10.1016\/j.actbio.2026.02.020_bib0010","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.apsb.2022.02.025","article-title":"Current approaches of nanomedicines in the market and various stage of clinical translation","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.actbio.2026.02.020_bib0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.actbio.2026.02.020_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216166","article-title":"Barrier permeation and improved nanomedicine delivery in tumor microenvironments","volume":"562","author":"Liu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.actbio.2026.02.020_bib0013","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","article-title":"Extracellular matrix in the tumor microenvironment and its impact on cancer therapy","volume":"6","author":"Henke","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"8","key":"10.1016\/j.actbio.2026.02.020_bib0014","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.actbio.2026.02.020_bib0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41568-023-00660-9","article-title":"Beyond genetics: driving cancer with the tumour microenvironment behind the wheel","volume":"24","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.actbio.2026.02.020_bib0016","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.actbio.2026.02.020_bib0017","article-title":"Bioresponsive materials","volume":"2","author":"Lu","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.actbio.2026.02.020_bib0018","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.actbio.2026.02.020_bib0019","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1039\/D5PM00137D","article-title":"Recent advances in biomedical applications of smart nanomaterials: a comprehensive review","volume":"2","author":"Goshisht","year":"2025","journal-title":"RSC Pharm."},{"issue":"9","key":"10.1016\/j.actbio.2026.02.020_bib0020","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actbio.2026.02.020_bib0021","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","article-title":"Controlling the biodistribution and clearance of nanomedicines","volume":"2","author":"Cabral","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.actbio.2026.02.020_bib0022","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2022.04.006","article-title":"Strategies of engineering nanomedicines for tumor retention","volume":"346","author":"Qian","year":"2022","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.actbio.2026.02.020_bib0023","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.apsb.2025.01.014","article-title":"DELIVER: the core principles for the clinic translation of nanomedicines","volume":"15","author":"Hu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.actbio.2026.02.020_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.05.032","article-title":"Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment","volume":"34","author":"Liu","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.actbio.2026.02.020_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103045","article-title":"Progress and challenges in the translation of cancer nanomedicines","volume":"85","author":"Tong","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.actbio.2026.02.020_bib0026","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2020.06.005","article-title":"Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers","volume":"157","author":"Fang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2026.02.020_bib0027","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jconrel.2022.04.031","article-title":"Advocation and advancements of EPR effect theory in drug delivery science: a commentary","volume":"346","author":"Hashida","year":"2022","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.actbio.2026.02.020_bib0028","doi-asserted-by":"crossref","first-page":"10920","DOI":"10.1021\/acs.chemrev.3c00062","article-title":"Tumor abnormality-oriented nanomedicine design","volume":"123","author":"Zhou","year":"2023","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.actbio.2026.02.020_bib0029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2026.02.020_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.03.012","article-title":"Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles","volume":"277","author":"Niu","year":"2018","journal-title":"J. Control. Release"},{"issue":"39","key":"10.1016\/j.actbio.2026.02.020_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202504909","article-title":"Dynamic size-change nanovaccine for enhancing lymph node deep penetration and eliciting robust antitumor immune responses","volume":"37","author":"Liu","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2026.02.020_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.152590","article-title":"Size-switchable and dual-targeting nanomedicine for cancer chemoimmunotherapy by potentiating deep tumor penetration and antitumor immunity","volume":"493","author":"Tang","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"7","key":"10.1016\/j.actbio.2026.02.020_bib0033","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1021\/acsnano.6b02326","article-title":"Smart superstructures with ultrahigh pH-sensitivity for targeting acidic tumor microenvironment: instantaneous size switching and improved tumor penetration","volume":"10","author":"Li","year":"2016","journal-title":"ACS Nano"},{"issue":"15","key":"10.1016\/j.actbio.2026.02.020_bib0034","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1073\/pnas.1522080113","article-title":"Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy","volume":"113","author":"Hong-Jun Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.actbio.2026.02.020_bib0035","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1021\/acs.accounts.8b00195","article-title":"Tumor-acidity-cleavable maleic acid amide (TACMAA): a powerful tool for designing smart nanoparticles to overcome delivery barriers in cancer nanomedicine","volume":"51","author":"Du","year":"2018","journal-title":"Acc. Chem. Res."},{"issue":"12","key":"10.1016\/j.actbio.2026.02.020_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/ppsc.202400049","article-title":"Nanoparticle-based drug delivery platform for simultaneous administration of phytochemicals and chemotherapeutics: emerging trends in cancer management","volume":"41","author":"Kawish","year":"2024","journal-title":"Part. Part. Syst. Charact."},{"key":"10.1016\/j.actbio.2026.02.020_bib0037","article-title":"Innovative chitosan-polyacrylic acid-MoS2 nanocomposite for enhanced and pH-responsive quercetin delivery","volume":"39","author":"Pourmadadi","year":"2024","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.actbio.2026.02.020_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.nwnano.2025.100094","article-title":"Engineering PAMAM dendrimers for optimized drug delivery","volume":"9","author":"Dehkordi","year":"2025","journal-title":"Nano Trends"},{"key":"10.1016\/j.actbio.2026.02.020_bib0039","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1007\/s10924-024-03280-y","article-title":"Stimuli-responsive dendrimers as nanoscale vectors in drug and gene delivery systems: a review study","volume":"32","author":"Fard","year":"2024","journal-title":"J. Polym. Environ."},{"key":"10.1016\/j.actbio.2026.02.020_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.153438","article-title":"Micelle-engineered nanoplatforms for precision oncology","volume":"495","author":"Gao","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2026.02.020_bib0041","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(01)00275-9","article-title":"In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy","volume":"72","author":"Sung Chul Kim","year":"2001","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.actbio.2026.02.020_bib0042","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1021\/acs.accounts.0c00589","article-title":"Self-assembling supramolecular dendrimers for biomedical applications: lessons learned from poly(amidoamine) dendrimers","volume":"53","author":"Lyu","year":"2020","journal-title":"Acc. Chem. Res."},{"issue":"7","key":"10.1016\/j.actbio.2026.02.020_bib0043","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215308120","article-title":"Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking","volume":"120","author":"Jiang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.actbio.2026.02.020_bib0044","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/EXP.20210003","article-title":"Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer","volume":"1","author":"Liu","year":"2021","journal-title":"Exploration"},{"key":"10.1016\/j.actbio.2026.02.020_bib0045","doi-asserted-by":"crossref","first-page":"eadu9948","DOI":"10.1126\/sciadv.adu9948","article-title":"Self-assembling dendrimer nanodrug formulations for decreased hERG-related toxicity and enhanced therapeutic efficacy","volume":"11","author":"Liu","year":"2025","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.actbio.2026.02.020_bib0046","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/pharmaceutics13071092","article-title":"A self-assembling amphiphilic peptide dendrimer-based drug delivery system for cancer therapy","volume":"13","author":"Zhu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.actbio.2026.02.020_bib0047","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1021\/acsami.4c12857","article-title":"Bola-amphiphilic dendrimer enhances Imatinib to target metastatic ovarian cancer via \u03b2-catenin-HRP2 signaling axis","volume":"17","author":"Shi","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"10.1016\/j.actbio.2026.02.020_bib0048","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1073\/pnas.1418494112","article-title":"Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance","volume":"112","author":"Wei","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.actbio.2026.02.020_bib0049","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/ar200193f","article-title":"A decade of bioorthogonal chemistry","volume":"44","author":"Bertozzi","year":"2011","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.actbio.2026.02.020_bib0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acs.chemrev.1c00484","article-title":"Click and bioorthogonal chemistry: the future of active targeting of nanoparticles for nanomedicines","volume":"122","author":"Taiariol","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.actbio.2026.02.020_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114463","article-title":"The in vivo fate of polymeric micelles","volume":"188","author":"Cai","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.actbio.2026.02.020_bib0052","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acs.chemrev.1c00484","article-title":"Click and bioorthogonal chemistry: the future of active targeting of nanoparticles for nanomedicines?","volume":"122","author":"Taiariol","year":"2021","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.actbio.2026.02.020_bib0053","first-page":"337","article-title":"PEGylation in anti-cancer therapy: an overview","volume":"11","author":"Mishra","year":"2016","journal-title":"Asian J. Pharm."},{"key":"10.1016\/j.actbio.2026.02.020_bib0054","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.actbio.2026.02.020_bib0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acscentsci.9b01139","article-title":"Size-tunable strategies for a tumor targeted drug delivery system","volume":"6","author":"Yu","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"21","key":"10.1016\/j.actbio.2026.02.020_bib0056","doi-asserted-by":"crossref","first-page":"20825","DOI":"10.1021\/acsnano.3c05853","article-title":"Size-dependent in vivo transport of nanoparticles: implications for delivery, targeting, and clearance","volume":"17","author":"Xu","year":"2023","journal-title":"ACS. Nano"},{"key":"10.1016\/j.actbio.2026.02.020_bib0057","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2016.09.004","article-title":"Tumor stroma-containing 3D spheroid arrays: a tool to study nanoparticle penetration","volume":"244","author":"Priwitaningrum","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2026.02.020_bib0058","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41592-025-02769-1","article-title":"From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research","volume":"22","author":"Rauner","year":"2025","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.actbio.2026.02.020_bib0059","first-page":"438","article-title":"Pancreatic cancer","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"10485","key":"10.1016\/j.actbio.2026.02.020_bib0060","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.actbio.2026.02.020_bib0061","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2023","journal-title":"Nat. Rev. Gastroenterol Hepatol."},{"key":"10.1016\/j.actbio.2026.02.020_bib0062","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving outcomes of patients with pancreatic cancer","volume":"22","author":"Dreyer","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.actbio.2026.02.020_bib0063","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1111\/febs.15583","article-title":"New insights into the activities and toxicities of the old anticancer drug doxorubicin","volume":"288","author":"Zanden","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.actbio.2026.02.020_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed. Pharmacother."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:06:52Z","timestamp":1791403612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":64,"alternative-id":["S1742706126000942"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.02.020","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Size-Transformable amphiphilic dendrimer-based drug Nanomicelles for enhanced tumor penetration in cancer chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}